| 1 |
Fargette C, Shulkin B, Jha A, Pacak K, Taïeb D. Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms. Front Oncol 2022;12:1081783. [PMID: 36733351 DOI: 10.3389/fonc.2022.1081783] [Reference Citation Analysis]
|
| 2 |
Amoako YA, van Eyssen A, Brink A. [123I]-metaiodobenzylguanidine imaging findings and outcome in patients with metastatic neuroblastoma. South African Journal of Oncology 2023;7. [DOI: 10.4102/sajo.v7i0.250] [Reference Citation Analysis]
|
| 3 |
Brink A, Hlongwa KN, More S. The Impact of PET/CT on Paediatric Oncology. Diagnostics (Basel) 2023;13. [PMID: 36673002 DOI: 10.3390/diagnostics13020192] [Reference Citation Analysis]
|
| 4 |
Samim A, Blom T, Poot AJ, Windhorst AD, Fiocco M, Tolboom N, Braat AJAT, Viol SLM, van Rooij R, van Noesel MM, Lam MGEH, Tytgat GAM, de Keizer B. [(18)F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study. Eur J Nucl Med Mol Imaging 2023;50:1146-57. [PMID: 36504277 DOI: 10.1007/s00259-022-06063-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Niessen VJA, Wenker STM, Lam MGEH, van Noesel MM, Poot AJ. Biologicals as theranostic vehicles in paediatric oncology. Nucl Med Biol 2022;114-115:58-64. [PMID: 36126433 DOI: 10.1016/j.nucmedbio.2022.09.001] [Reference Citation Analysis]
|
| 6 |
Noriega-álvarez E, Orduña Díez M, Sanz Viedma S, Peiró Valgañón V, Velasco Nuño M, Orcajo Rincón J, Rodríguez Alfonso B, Domínguez Gadea L. Aportaciones de la medicina nuclear en la enfermedad musculoesquelética tumoral maligna en niños. Revista Española de Medicina Nuclear e Imagen Molecular 2022;41:395-407. [DOI: 10.1016/j.remn.2022.09.001] [Reference Citation Analysis]
|
| 7 |
Lai HA, Sharp SE, Bhatia A, Dietz KR, McCarville B, Rajderkar D, Servaes S, Shulkin BL, Singh S, Trout AT, Watal P, Parisi MT. Imaging of pediatric neuroblastoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer 2022;:e29974. [PMID: 36184716 DOI: 10.1002/pbc.29974] [Reference Citation Analysis]
|
| 8 |
Noriega-álvarez E, Orduña Díez M, Sanz Viedma S, Peiró Valgañón V, Velasco Nuño M, Orcajo Rincón J, Rodríguez Alfonso B, Domínguez Gadea L. Contributions of nuclear medicine to malignant musculoskeletal tumor disease in children. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2022. [DOI: 10.1016/j.remnie.2022.09.013] [Reference Citation Analysis]
|
| 9 |
Littooij AS, de Keizer B. Imaging in neuroblastoma. Pediatr Radiol 2022. [PMID: 36063183 DOI: 10.1007/s00247-022-05489-2] [Reference Citation Analysis]
|
| 10 |
Lorusso M, Rufini V, DE Crea C, Pennestrì F, Bellantone R, Raffaelli M. Integration of molecular imaging in the personalized approach of patients with adrenal masses. Q J Nucl Med Mol Imaging 2022;66:104-15. [PMID: 35343669 DOI: 10.23736/S1824-4785.22.03449-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Feng L, Qian L, Yang S, Ren Q, Zhang S, Qin H, Wang W, Wang C, Zhang H, Yang J. Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma. BMC Med Imaging 2022;22. [DOI: 10.1186/s12880-022-00828-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Panachan J, Rojsirikulchai N, Pongsakul N, Khowawisetsut L, Pongphitcha P, Siriboonpiputtana T, Chareonsirisuthigul T, Phornsarayuth P, Klinkulab N, Jinawath N, Chiangjong W, Anurathapan U, Pattanapanyasat K, Hongeng S, Chutipongtanate S. Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma. Cancers (Basel) 2022;14:2627. [PMID: 35681607 DOI: 10.3390/cancers14112627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 13 |
Fortunati E, Argalia G, Zanoni L, Fanti S, Ambrosini V. New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms. Curr Treat Options Oncol 2022. [PMID: 35325412 DOI: 10.1007/s11864-022-00967-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Alenezi SA, Elgazzar AH. Endocrine System. The Pathophysiologic Basis of Nuclear Medicine 2022. [DOI: 10.1007/978-3-030-96252-4_6] [Reference Citation Analysis]
|
| 15 |
Filippi L, Frantellizzi V, Sidrak MMA, Gorica J, Scippa S, Chiaravalloti A, Schillaci O, Bagni O, De Vincentis G. Radiotheranostic Agents Targeting Neuroblastoma: State-of-the-Art and Emerging Perspectives. Onco 2021;1:123-139. [DOI: 10.3390/onco1020011] [Reference Citation Analysis]
|
| 16 |
Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT. Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy. Front Endocrinol (Lausanne) 2021;12:728088. [PMID: 34539578 DOI: 10.3389/fendo.2021.728088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 17 |
Foppen W, Tolboom N, de Jong PA. Systems Radiology and Personalized Medicine. J Pers Med 2021;11:769. [PMID: 34442413 DOI: 10.3390/jpm11080769] [Reference Citation Analysis]
|
| 18 |
Tang T, Chang B, Zhang M, Sun T. Nanoprobe-mediated precise imaging and therapy of glioma. Nanoscale Horiz 2021;6:634-50. [PMID: 34110340 DOI: 10.1039/d1nh00182e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
